PharMEDium Announces the Extension of Its Agreement With Novation to Deliver Outsourced Pharmacy Compounding Services

LAKE FOREST, Ill., Jan. 19, 2011 /PRNewswire/ -- David N. Jonas, Chairman and CEO of PharMEDium Healthcare Corporation announced the extension of its agreement with Novation to deliver outsourced pharmacy compounding services.  Jonas said, "We are delighted for the opportunity extended to us to continue to be the partner of choice for Novation's outsourced pharmacy compounding and admixture services.  Novation shares our core values of providing the highest quality sterile intravenous admixture compounding services, which facilitate the best clinical care and emphasize patient safety first."

Ross Day, R.Ph., Novation Portfolio Executive, commented, "PharMEDium's proven record of quality, customer service, and experience has been a clear asset to our organization's contract portfolio.  We are excited to extend our contract with PharMEDium, a leader in this business segment, to deliver the best patient care backed and enhanced by market-leading suppliers."

Novation, based in Irving, Texas, delivers savings to nearly 25,000 VHA Inc. and the University HealthSystem Consortium (UHC) member organizations and 5,500 Provista members covering 28,000 sites. By combining scale and expertise with data-driven tools and information, Novation offers the most extensive range of advanced contracting services in the industry. In 2009, VHA, UHC and Provista members used Novation and alliance contracts to purchase $37.8 billion in products and services.  Jennifer Adams, Vice President, Sales, for PharMEDium, stated, "We are excited to continue our affiliation with Novation, the industry's premier supply contracting company."

PharMEDium is the national leading provider of pharmacy sterile intravenous admixture compounding services. The PharMEDium network of state licensed and federally registered compounding centers provides trusted solutions to hospitals throughout the United States. PharMEDium complies with all applicable state laws and FDA regulations, including USP Chapter (797), and DEA requirements.  For more information on PharMEDium, visit www.pharmedium.com.

SOURCE PharMEDium